Qpex Bio Mockup List - 7pm Tues - 2 burn
  • Home

  • Pipeline

  • Our Team

  • News

  • Events

  • Publications

  • Careers

  • Contact

  • More

    Use tab to navigate through the menu items.

    News

    2022

    04/21/2022 Qpex Biopharma Announces Presentation of Clinical Data at ECCMID 2022 Meeting
    03/30/2022 Qpex Biopharma Announces Publication of Data in Nature Communications
    01/19/2022 Qpex Announces Progress on Three Clinical Stage Programs

    2021

    06/17/2021 Qpex Biopharma Initiates Phase 1 Study of QPX9003
    05/12/2021 Qpex Biopharma Initiates Phase 1 Study of ORAvance™
    01/05/2021 Qpex Strengthens Leadership Team and Provides Update on BARDA Award

    2020

    12/03/2020 Qpex Initiates Phase 1 Clinical Trial of QPX7728

    2019

    12/2019 Qpex Biopharma Announces Exercise of $20 Million Option by BARDA
    10/2019 - Qpex Biopharma and Brii Biosciences Enter Into a Strategic Collaboration
    09/2019 - Qpex Biopharma to Present its Anti-infective Portfolio at IDWeek 2019
    06/2019 - Qpex to Provide First Public Presentations at ASM Microbe Meeting
    04/2019 - Qpex Licenses Polymyxin Antimicrobial Program from Monash University

    2018

    10/2018 - Qpex Biopharma Announces Closing of $33 Million

    Home

    Pipeline

    Our Team

    News

    Events
    ​
    Publications
    ​
    Careers
    ​
    Contact
    ​

    Qpex Biopharma, Inc.

    6275 Nancy Ridge Drive, Suite 100

    San Diego, CA 92121

    T: (858) 500-8366

    Qpex%2520Bio%2520Mockup%2520List%2520-%2
    • Twitter
    • LinkedIn